cbdMD (YCBD) Interest Coverage Ratio Growth (1y) (2017 - 2026)
cbdMD (YCBD) Interest Coverage Ratio Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -83.16% |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 128.45% |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -97.39% |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | -8.29% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | cbdMD | 5.41 Mn | 3.29 Mn | 3.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 53.07% |
| Dec 31, 2025 | -70.95% |
| Sep 30, 2025 | -297.53% |
| Jun 30, 2025 | -331.41% |
| Mar 31, 2025 | -666.60% |
| Dec 31, 2024 | 46.81% |
| Sep 30, 2024 | 99.97% |
| Jun 30, 2024 | 79.66% |
| Mar 31, 2024 | -58.52% |
| Dec 31, 2023 | -99.21% |
| Sep 30, 2023 | -187.78% |
| Jun 30, 2023 | 91.47% |
| Mar 31, 2023 | -102.32% |
| Dec 31, 2022 | 98.64% |
| Sep 30, 2022 | 917.64% |
| Jun 30, 2022 | -645.50% |
| Mar 31, 2022 | 373.65% |
| Dec 31, 2021 | -758.31% |
| Sep 30, 2021 | 155.22% |
| Jun 30, 2021 | -599.53% |